MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-04-2025
Masimo Corporation EV - Enterprise Value 2011-2025 | MASI
Annual EV - Enterprise Value Masimo Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10.4 B | 8.33 B | 11.1 B | 11.7 B | - | 8.62 B | 6.01 B | 4.71 B | 1.9 B | 1.53 B | - | 1.74 B | 1.24 B | 1.63 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 11.7 B | 1.24 B | 5.74 B |
EV - Enterprise Value of other stocks in the Medical instruments industry
| Issuer | EV - Enterprise Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
BioLife Solutions
BLFS
|
1.09 B | $ 24.29 | -0.41 % | $ 1.12 B |  USA |
 |
Baxter International
BAX
|
34.3 B | $ 19.77 | 3.21 % | $ 10.1 B | USA |
 |
Becton, Dickinson and Company
BDX
|
55.5 B | $ 200.24 | -0.32 % | $ 57.6 B | USA |
 |
Harvard Bioscience
HBIO
|
248 M | $ 0.71 | -3.68 % | $ 30.1 M | USA |
 |
Luminex Corporation
LMNX
|
456 M | - | - | $ 1.75 B | USA |
 |
ICU Medical
ICUI
|
3.34 B | $ 148.24 | -0.13 % | $ 3.62 B | USA |
 |
iRhythm Technologies
IRTC
|
3.91 B | $ 171.44 | 1.55 % | $ 5.35 B | USA |
 |
Akers Biosciences, Inc.
AKER
|
631 M | - | -9.52 % | $ 20.6 M | USA |
 |
Repro Med Systems
KRMD
|
93.3 M | $ 5.85 | 1.21 % | $ 267 M | USA |
 |
LeMaitre Vascular
LMAT
|
2.26 B | $ 84.03 | 0.04 % | $ 1.89 B | USA |
 |
Ekso Bionics Holdings
EKSO
|
17.1 M | $ 4.68 | 0.21 % | $ 94.4 M | USA |
 |
Merit Medical Systems
MMSI
|
6.6 B | $ 86.04 | -0.76 % | $ 5.01 B | USA |
 |
Antares Pharma, Inc.
ATRS
|
758 M | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
726 M | - | -1.18 % | $ 3.4 B | USA |
 |
CRH Medical Corporation
CRHM
|
66.3 M | - | - | $ 282 M | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
6.3 B | - | -0.05 % | $ 10.3 B | USA |
 |
Varian Medical Systems, Inc.
VAR
|
451 M | - | -0.02 % | $ 16.3 B | USA |
 |
Alcon
ALC
|
7.12 B | $ 79.18 | 0.48 % | $ 40.4 B |  Schweiz |
 |
AtriCure
ATRC
|
1.93 B | $ 41.37 | -2.39 % | $ 1.94 B | USA |
 |
Atrion Corporation
ATRI
|
636 M | - | - | $ 810 M | USA |
 |
ResMed
RMD
|
36.5 B | $ 253.22 | 0.38 % | $ 37 B | USA |
 |
electroCore
ECOR
|
-1.64 M | $ 4.81 | 1.23 % | $ 26.5 K | USA |
 |
AngioDynamics
ANGO
|
396 M | $ 13.35 | 1.6 % | $ 545 M | USA |
 |
The Cooper Companies
COO
|
20.4 B | $ 81.0 | -1.32 % | $ 16.1 B | USA |
 |
STAAR Surgical Company
STAA
|
800 M | $ 23.62 | -2.11 % | $ 1.16 B | USA |
 |
STERIS plc
STE
|
27.5 B | $ 252.38 | 0.23 % | $ 24.9 B | USA |
 |
Stereotaxis
STXS
|
216 M | $ 2.37 | - | $ 191 M | USA |
 |
Glaukos Corporation
GKOS
|
4.69 B | $ 112.03 | 2.89 % | $ 5.43 B | USA |
 |
Haemonetics Corporation
HAE
|
2.76 B | $ 78.83 | -5.58 % | $ 3.97 B | USA |
 |
InfuSystem Holdings
INFU
|
197 M | $ 9.18 | -0.65 % | $ 190 M | USA |
 |
Isoray
ISR
|
13.3 M | - | 0.03 % | $ 108 M | USA |
 |
Utah Medical Products
UTMD
|
162 M | $ 58.21 | 0.19 % | $ 211 M | USA |
 |
Intuitive Surgical
ISRG
|
203 B | $ 554.04 | 2.16 % | $ 197 B | USA |
 |
OraSure Technologies
OSUR
|
60.6 M | $ 2.49 | -0.2 % | $ 185 M | USA |
 |
DENTSPLY SIRONA
XRAY
|
7.04 B | $ 11.4 | -1.47 % | $ 2.32 B | USA |
 |
Microbot Medical
MBOT
|
13.1 M | $ 2.27 | -6.02 % | $ 23.2 M |  Israel |
 |
Milestone Scientific
MLSS
|
70.1 M | $ 0.37 | -5.1 % | $ 29.5 M | USA |
 |
Nephros
NEPH
|
21.7 M | $ 4.96 | -1.29 % | $ 51.5 M | USA |
 |
NeuroMetrix
NURO
|
8.29 M | - | 5.05 % | $ 9.02 M | USA |
 |
Envista Holdings Corporation
NVST
|
2.61 B | $ 22.07 | 0.46 % | $ 3.8 B | USA |
 |
Pro-Dex
PDEX
|
175 M | $ 42.11 | -2.94 % | $ 138 M | USA |
 |
Pulse Biosciences
PLSE
|
389 M | $ 14.09 | -1.05 % | $ 677 M | USA |
 |
Predictive Oncology
POAI
|
12.7 M | - | - | $ 32.4 M | USA |
 |
Repligen Corporation
RGEN
|
126 M | $ 158.06 | 0.43 % | $ 8.81 M | USA |
 |
Retractable Technologies
RVP
|
90.3 M | $ 0.84 | 1.63 % | $ 25.1 M | USA |
 |
Teleflex Incorporated
TFX
|
8.74 B | $ 126.54 | -0.27 % | $ 5.93 B | USA |
 |
West Pharmaceutical Services
WST
|
15.9 B | $ 269.57 | 0.76 % | $ 19.7 B | USA |